miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation.

dc.contributor.authorLópez-Beas, Javier
dc.contributor.authorCapilla-González, Vivian
dc.contributor.authorAguilera, Yolanda
dc.contributor.authorMellado, Nuria
dc.contributor.authorLachaud, Christian C
dc.contributor.authorMartín, Franz
dc.contributor.authorSmani, Tarik
dc.contributor.authorSoria, Bernat
dc.contributor.authorHmadcha, Abdelkrim
dc.date.accessioned2025-01-07T17:26:02Z
dc.date.available2025-01-07T17:26:02Z
dc.date.issued2018-06-15
dc.description.abstractHuman pluripotent stem cells retain the extraordinary capacity to differentiate into pancreatic beta cells. For this particular lineage, more effort is still required to stress the importance of developing an efficient, reproducible, easy, and cost-effective differentiation protocol to obtain more mature, homogeneous, and functional insulin-secreting cells. In addition, microRNAs (miRNAs) have emerged as a class of small non-coding RNAs that regulate many cellular processes, including pancreatic differentiation. Some miRNAs are known to be preferentially expressed in islets. Of note, miR-375 and miR-7 are two of the most abundant pancreatic miRNAs, and they are necessary for proper pancreatic islet development. Here we provide new insight into specific miRNAs involved in pancreatic differentiation. We found that miR-7 is differentially expressed during the differentiation of human embryonic stem cells (hESCs) into a beta cell-like phenotype and that its modulation plays an important role in generating mature pancreatic beta cells. This strategy may be exploited to optimize the potential for in vitro differentiation of hESCs into insulin-producing beta-like cells for use in preclinical studies and future clinical applications as well as the prospective uses of miRNAs to improve this process.
dc.identifier.doi10.1016/j.omtn.2018.06.002
dc.identifier.issn2162-2531
dc.identifier.pmcPMC6070677
dc.identifier.pmid30195784
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC6070677/pdf
dc.identifier.unpaywallURLhttp://www.cell.com/article/S216225311830129X/pdf
dc.identifier.urihttps://hdl.handle.net/10668/28373
dc.journal.titleMolecular therapy. Nucleic acids
dc.journal.titleabbreviationMol Ther Nucleic Acids
dc.language.isoen
dc.organizationCentro Andaluz de Biología Molecular (CABIMER)
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationCentro Andaluz de Biología Molecular (CABIMER)
dc.organizationInstituto de Investigación Biomédica de Sevilla (IBIS)
dc.page.number463-477
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectGene Ontology
dc.subjectHS181
dc.subjectKEGG
dc.subjectPdx-1
dc.subjectbeta cell
dc.subjectdifferentiation
dc.subjectendoderm
dc.subjecthESCs
dc.subjectinsulin
dc.subjectmaturation
dc.subjectmiR7
dc.subjectmicroRNA
dc.subjectpluripotent
dc.titlemiR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC6070677.pdf
Size:
3.55 MB
Format:
Adobe Portable Document Format